Strongbridge Biopharma plc Overview

Strongbridge Biopharma plc Research & Development

Research & Development expenses for SBBP.

Quarterly R&D Expenses

$5.40M

↓ 12.27% YoY

As of Jun 30, 2021

Annual R&D Expenses (TTM)

$23.33M

↓ 20.34% YoY

Trailing 12 months ending Jun 30, 2021

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin